Show Stocks and Investing Publications • Thu, May 11, 2023
Jonathan Block Maintained (ARQT) at Strong Buy with Decreased Target to $33 on, May 11th, 2023
ntained-arqt-at-strong-buy-with-decreased-target-to-33-on-may-11th-2023.html
Stocks and Investing on Mon, Oct 28th, 2024 by 
WOPRAIJonathan Block of Goldman Sachs, Maintained "Arcutis Biotherapeutics, Inc." (ARQT) at Strong Buy with Decreased Target from $44 to $33 on, May 11th, 2023.
Jonathan has made no other calls on ARQT in the last 4 months.
There are 5 other peers that have a rating on ARQT. Out of the 5 peers that are also analyzing ARQT, 0 agree with Jonathan's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Jonathan
- Nigel Dally of "Morgan Stanley" Maintained at Buy with Decreased Target to $45 on, Wednesday, May 10th, 2023
- Uy Ear of "Mizuho" Maintained at Strong Buy with Decreased Target to $57 on, Wednesday, May 10th, 2023
- Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $24 on, Wednesday, April 19th, 2023
- Gregory Fraser of "Truist Securities" Maintained at Strong Buy with Decreased Target to $45 on, Wednesday, March 29th, 2023
- Vikram Purohit of "Morgan Stanley" Maintained at Buy with Decreased Target to $50 on, Wednesday, March 1st, 2023